Bsb Pharma Analytic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Revenue Growth 62.18%
- Profit Growth 80.17%
- Ebitda 55.98%
- Net Worth 113.32%
- Total Assets 96.46%
About Bsb Pharma Analytic
Bsb Pharma Analytic Private Limited (BPAPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 July 2020 (Four years and six months 26 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Babita Mishra and Vishal Mishra serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24110MH2020PTC341591
-
Company No.
341591
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jul 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Bsb Pharma Analytic Private Limited offer?
Bsb Pharma Analytic Private Limited offers a wide range of products and services, including Packaging Caps & Seals, Packing Seals, Analyzers & Analytical Instruments, High Pressure Liquid Chromatography System, Metal Caps, Cap Closures, Infusion Syringes & Supplies, Syringe Filter, Vials and Ampoules, Brackets, Holder & Hardware Fittings.
Who are the key members and board of directors at Bsb Pharma Analytic?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Babita Mishra
|
Director | 08-Jul-2020 | Current |
|
Vishal Mishra
|
Director | 08-Jul-2020 | Current |
Financial Performance of Bsb Pharma Analytic.
Bsb Pharma Analytic Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 62.18% increase. The company also saw a substantial improvement in profitability, with a 80.17% increase in profit. The company's net worth Soared by an impressive increase of 113.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bsb Pharma Analytic?
In 2022, Bsb Pharma Analytic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2022 | Axis Bank Limited | ₹4.00 M | Open |
How Many Employees Work at Bsb Pharma Analytic?
Bsb Pharma Analytic has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bsb Pharma Analytic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bsb Pharma Analytic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.